biblio

Export 7 results:
Filters: Author is Choudhari, Amit  [Clear All Filters]
Journal Article
, ,, Wadgaonkar, P. P., Tapase, S. R., Kodam, K. M., Choudhari, A., and Sarkar, D., “Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents”, Bioorganic Chemistry, vol. 85, pp. 475-486, 2019.
A. Atmaram Upare, Gadekar, P. K., Sivaramakrishnan, H., Naik, N., Khedkar, V. M., Sarkar, D., Choudhari, A., and S. Roopan, M., “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
M. S. Tambe, Choudhari, A., Sarkar, D., Sangshetti, J., Patil, R., and Gholap, S. S., “Design, synthesis and biological screening of novel 1,3,4-oxadiazoles as antitubercular agents”, Chemistryselect, vol. 3, no. 47, pp. 13304-13310, 2018.
N. V. Puranik, Srivastava, P., Swami, S., Choudhari, A., and Sarkar, D., “Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against mycobacterium tuberculosis”, RSC Advances, vol. 8, no. 19, pp. 10634-10643, 2018.
T. S. Chitre, Patil, S. M., Sujalegaonkar, A. G., Asgaonkar, K. D., Khedkar, V. M., Garud, D. R., Jha, P. C., Gaikwad, S. Y., Kulkarni, S., Choudhari, A., and Sarkar, D., “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
V. Shinde, Mahulikar, P., Mhaske, P. C., Chakraborty, S., Choudhari, A., Phalle, S., Choudhari, P., and Sarkar, D., “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
Y. Patil, Shingare, R., Choudhari, A., Borkute, R., Sarkar, D., and Madje, B. R., “Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents”, Archiv Der Pharmazie, vol. 351, no. 8, p. e1800040, 2018.